Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Sonia Esparza"'
Autor:
Steven M. Johnson, Daniel R. Richardson, Jonathan Galeotti, Sonia Esparza, Anqi Zhu, Yuri Fedoriw, Karen E. Weck, Matthew C. Foster, Catherine C. Coombs, Joshua F. Zeidner, Nathan D. Montgomery
Publikováno v:
HemaSphere, Vol 3, Iss 5 (2019)
Externí odkaz:
https://doaj.org/article/551ed8b5d9a34c68970a760ebccaa016
Autor:
Scott R Plotkin, Miriam A Bredella, Wenli Cai, Ara Kassarjian, Gordon J Harris, Sonia Esparza, Vanessa L Merker, Lance L Munn, Alona Muzikansky, Manor Askenazi, Rosa Nguyen, Ralph Wenzel, Victor F Mautner
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e35711 (2012)
Patients with neurofibromatosis 1 (NF1), NF2, and schwannomatosis are at risk for multiple nerve sheath tumors and premature mortality. Traditional magnetic resonance imaging (MRI) has limited ability to assess disease burden accurately. The aim of t
Externí odkaz:
https://doaj.org/article/fa01fa245d85418b9a10cfca1a9dd5da
Autor:
Sonia Esparza, Daniel R. Richardson, Joshua F. Zeidner, Melissa Matson, Jonathan Galeotti, Benyam Muluneh, Matthew C. Foster, Catherine C. Coombs, Katarzyna Jamieson, Nathan D. Montgomery
Publikováno v:
Br J Haematol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c745947b80d268761a8e8c0a710724aa
https://doi.org/10.1111/bjh.16235
https://doi.org/10.1111/bjh.16235
Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemia
Autor:
Dominic T. Moore, Daniel R. Richardson, David M Swoboda, Mohammad Hussaini, Matthew C. Foster, Catherine C. Coombs, Steven M Johnson, Nathan D. Montgomery, Onyee Chan, Sonia Esparza, David A. Sallman, Hendrick W. van Deventer, Jonathan Galeotti, Joshua F. Zeidner
Publikováno v:
Am J Hematol
ASXL1 and SRSF2 mutations in AML are frequently found in patients with preexisting myeloid malignancies and are individually associated with poor outcomes. In this multi-institutional retrospective analysis, we assessed the genetic features and clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8b4311df4e8bc74ef56adb839cab9b1
https://europepmc.org/articles/PMC10284351/
https://europepmc.org/articles/PMC10284351/
Autor:
Joshua F. Zeidner, Sonia Esparza
Publikováno v:
Cancer Pharmacology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4f84eb83dee5e36e6834461e2f9d5df
https://doi.org/10.1891/9780826162045.0016
https://doi.org/10.1891/9780826162045.0016
Autor:
Anqi Zhu, Jonathan Galeotti, Steven M Johnson, Daniel R. Richardson, Nathan D. Montgomery, Joshua F. Zeidner, Yuri Fedoriw, Karen E. Weck, Sonia Esparza, Matthew C. Foster, Catherine C. Coombs
Publikováno v:
HemaSphere
HemaSphere, Vol 3, Iss 5 (2019)
HemaSphere, Vol 3, Iss 5 (2019)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b37fa423e5faa0bb4f45db34151d3ca6
http://europepmc.org/articles/PMC6919468
http://europepmc.org/articles/PMC6919468
Autor:
Nathan D. Montgomery, Daniel R. Richardson, Anastasia Ivanova, David A. Sallman, Jonathan Galeotti, Matthew C. Foster, Catherine C. Coombs, Sonia Esparza, Onyee Chan, Joshua F. Zeidner, Steven M Johnson, David M Swoboda
Publikováno v:
Blood. 134:2598-2598
Background: Advances in the understanding of the genetic determinants of AML and the widespread use of next-generation sequencing (NGS) have led to the refinement of prognostically distinct molecular subgroups. Mutations in ASXL1 and SRSF2, which are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::122f008d533ff52b1dc278cd902fc608
https://doi.org/10.1182/blood-2019-122929
https://doi.org/10.1182/blood-2019-122929
Autor:
Sonia Esparza, Amy E. DeZern, Nancy Vogler, Joshua F. Zeidner, Laura Blanchard, Cassiopeia Frank, William Churchwell, Anastasia Ivanova, Dominic T. Moore, Hendrik W. van Deventer, Jonathan Webster, Ashley Reed, Leo Luznik, Benjamin G. Vincent, Ivana Gojo, Katarzyna Jamieson, Matthew C. Foster, B. Douglas Smith, Catherine C. Coombs, Mark J. Levis, Sean Gallagher, Melissa Matson, Gabrielle T. Prince, Jonathan S. Serody
Publikováno v:
Blood. 134:831-831
Background: Despite recent advances in the therapeutic armamentarium for AML, outcomes remain dismal for patients (pts) with relapsed/refractory (R/R) AML. Response rates with high dose cytarabine (HiDAC) salvage chemotherapy are approximately 20%. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a3a6ba2e15acf185d9f00fe1f542099
https://doi.org/10.1182/blood-2019-126065
https://doi.org/10.1182/blood-2019-126065
Autor:
Scott R. Plotkin, Fawn Leigh, Kelly B. Smith, Alona Muzikansky, Sonia Esparza, Elyse R. Park, Daphne L. Wang
Publikováno v:
Genetics in Medicine. 14:977-982
Although patients with neurofibromatosis are predisposed to multiple nerve sheath tumors that can develop anywhere in the body and cause significant morbidity (e.g., hearing loss; pain), little research has examined emotional correlates of neurofibro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67f0ec81450cf0baf77b9d4eb6b7094e
https://doi.org/10.1038/gim.2012.85
https://doi.org/10.1038/gim.2012.85
Publikováno v:
The Oncologist. 17:1317-1322
Background. Schwannomatosis is a recently recognized form of neurofibromatosis characterized by multiple noncutaneous schwannomas, a histologically benign nerve sheath tumor. As more cases are identified, the reported phenotype continues to expand an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc1398ba6c029affd04c02e9d701f5cb
https://doi.org/10.1634/theoncologist.2012-0162
https://doi.org/10.1634/theoncologist.2012-0162